Published in Science on October 12, 1990
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Pathways towards and away from Alzheimer's disease. Nature (2004) 8.72
Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochem J (1999) 8.68
Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A (1999) 5.75
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A (1994) 4.33
Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci (2008) 3.21
Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A (1993) 3.16
Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1992) 2.84
Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci U S A (1993) 2.57
Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol (1991) 2.47
Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc Natl Acad Sci U S A (1993) 2.41
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.39
Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci U S A (1997) 2.35
pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J (1991) 2.33
The toxicity in vitro of beta-amyloid protein. Biochem J (1995) 2.17
Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J (1994) 1.99
A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys J (2001) 1.96
Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A (1994) 1.94
An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc Natl Acad Sci U S A (1991) 1.93
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A (1993) 1.92
Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol (2004) 1.90
Microglial activation and chronic neurodegeneration. Neurotherapeutics (2010) 1.87
Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci U S A (2002) 1.87
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A (1994) 1.79
Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A (2007) 1.77
Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.77
Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. Am J Pathol (2005) 1.77
BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol Dis (2006) 1.77
Solvent effects on self-assembly of beta-amyloid peptide. Biophys J (1995) 1.74
Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape. Chem Rev (2010) 1.62
Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A (1995) 1.60
Effects of injected Alzheimer beta-amyloid cores in rat brain. Proc Natl Acad Sci U S A (1991) 1.58
Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics (2008) 1.58
Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem (2008) 1.57
Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. Proc Natl Acad Sci U S A (2004) 1.53
ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem (2011) 1.52
Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A (2002) 1.51
Zn2+ interaction with Alzheimer amyloid beta protein calcium channels. Proc Natl Acad Sci U S A (1996) 1.49
Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem (1994) 1.46
Senile plaques do not progressively accumulate with normal aging. Acta Neuropathol (1994) 1.45
Senile plaques in temporal lobe epilepsy. Acta Neuropathol (1994) 1.44
Theoretical models of the ion channel structure of amyloid beta-protein. Biophys J (1994) 1.44
Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc Natl Acad Sci U S A (1999) 1.43
Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Am J Pathol (1991) 1.43
Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. Biophys J (1997) 1.41
Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci U S A (1992) 1.41
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (1995) 1.40
Copper in the brain and Alzheimer's disease. J Biol Inorg Chem (2009) 1.40
Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory. Ann Neurol (2011) 1.35
Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol (2005) 1.34
Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest (2012) 1.32
Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study. BMC Neurol (2010) 1.32
NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. Proc Natl Acad Sci U S A (1995) 1.32
The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol (2006) 1.29
Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol (1998) 1.29
Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide. Biophys J (1994) 1.28
The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J Neurosci (2011) 1.26
Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide. Biophys J (1993) 1.25
Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy. Neurotox Res (2009) 1.24
Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family. Mol Neurodegener (2006) 1.23
HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS One (2008) 1.23
Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci U S A (1991) 1.23
Amyloid-β as a modulator of synaptic plasticity. J Alzheimers Dis (2010) 1.22
Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol (2005) 1.19
Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci U S A (1990) 1.18
Spontaneous solubilization of membrane-bound human testis angiotensin-converting enzyme expressed in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1991) 1.17
Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc Natl Acad Sci U S A (1993) 1.16
Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med (2008) 1.16
Architecture of the Alzheimer's A beta P ion channel pore. J Membr Biol (2004) 1.16
Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy. Proc Natl Acad Sci U S A (2002) 1.16
Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4. Diabetologia (2008) 1.14
Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of Abeta species on lipid bilayers. Biochemistry (2010) 1.13
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum Genomics (2010) 1.12
beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci U S A (1996) 1.12
Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease. Proc Natl Acad Sci U S A (1991) 1.12
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation. J Biol Chem (2010) 1.11
Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling. Protein Sci (1993) 1.11
Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. Biochim Biophys Acta (2007) 1.11
Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci U S A (1994) 1.09
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. J Cell Mol Med (2009) 1.09
Stepwise dynamics of epitaxially growing single amyloid fibrils. Proc Natl Acad Sci U S A (2007) 1.08
S100B and APP promote a gliocentric shift and impaired neurogenesis in Down syndrome neural progenitors. PLoS One (2011) 1.07
Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease. Mol Biol Cell (2008) 1.07
Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J Cell Biol (1995) 1.07
Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc Natl Acad Sci U S A (1994) 1.06
Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons. Eur J Neurosci (2007) 1.06
Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiol Dis (2009) 1.06
Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med (2002) 1.06
Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys J (2005) 1.05
Targets for AD treatment: conflicting messages from γ-secretase inhibitors. J Neurochem (2011) 1.05
Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J Biol Chem (2010) 1.04
Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease. Neurobiol Dis (2006) 1.04
A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. FASEB J (2012) 1.03
Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc Natl Acad Sci U S A (1995) 1.01
Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta (2008) 1.01
Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology. J Neurochem (2013) 1.01
Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses. Int J Alzheimers Dis (2011) 1.01
Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease. Brain (2015) 1.00
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc Natl Acad Sci U S A (1996) 0.99
On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A (1996) 4.75
Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1987) 4.04
Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A (1997) 3.40
Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J Neurochem (1986) 3.31
X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc Natl Acad Sci U S A (1986) 3.14
Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. Biochemistry (1990) 2.93
Myelin membrane structure at 10 A resolution. Nat New Biol (1971) 2.92
Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction. Biophys J (1993) 2.77
Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein. Biochemistry (1992) 2.36
pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J (1991) 2.33
Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles. Proc Natl Acad Sci U S A (1984) 2.22
Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils. Biophys J (1998) 2.22
An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc Natl Acad Sci U S A (1991) 1.93
Morphology and antibody recognition of synthetic beta-amyloid peptides. J Neurosci Res (1991) 1.77
Purification and chemical characterization of type 1 pili isolated from Klebsiella pneumoniae. J Biol Chem (1982) 1.74
Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron (1994) 1.71
Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging. Brain Res (1988) 1.59
Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues. J Mol Biol (1994) 1.52
Water diffusion, T(2), and compartmentation in frog sciatic nerve. Magn Reson Med (1999) 1.51
An ultrastructural analysis of tissue surrounding a microdialysis probe. J Neurosci Methods (1999) 1.49
X-ray diffraction of scrapie prion rods and PrP peptides. J Mol Biol (1995) 1.47
Membrane interactions in nerve myelin. I. Determination of surface charge from effects of pH and ionic strength on period. Biophys J (1988) 1.21
Compact myelin exists in the absence of basic protein in the shiverer mutant mouse. Nature (1980) 1.20
Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J Neurochem (1992) 1.18
Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci U S A (1990) 1.18
Transfection of PC12 cells with the human GAP-43 gene: effects on neurite outgrowth and regeneration. Brain Res Mol Brain Res (1990) 1.18
Amyloid-like properties of a synthetic peptide corresponding to the carboxy terminus of beta-amyloid protein precursor. Arch Biochem Biophys (1992) 1.14
Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro. J Neurochem (1993) 1.12
Membrane structure in isolated and intact myelins. Biophys J (1989) 1.11
Comparative diffraction studies on myelin membranes. Ann N Y Acad Sci (1972) 1.11
Commentary and perspective on studies of beta amyloid neurotoxicity. Neurobiol Aging (1993) 1.09
Folding and function of the myelin proteins from primary sequence data. J Neurosci Res (1991) 1.08
Myelination in the developing human brain: biochemical correlates. Neurochem Res (1994) 1.07
Cytologic and molecular analysis of 46,XXq- cells to identify a DNA segment that might serve as a probe for a putative human X chromosome inactivation center. Hum Genet (1983) 1.05
X-ray diffraction analysis of tendon collagen at ambient and cryogenic temperatures: role of hydration. Int J Biol Macromol (1997) 1.03
Membrane interactions in nerve myelin: II. Determination of surface charge from biochemical data. Biophys J (1988) 1.01
Myelin structure transformed by dimethylsulfoxide. Proc Natl Acad Sci U S A (1975) 1.00
Structural changes in a hydrophobic domain of the prion protein induced by hydration and by ala-->Val and pro-->Leu substitutions. J Mol Biol (2000) 1.00
Multilamellar packing of myelin modeled by lipid-bound MBP. J Neurosci Res (2000) 0.99
Visualization of nonstructural changes in early white matter development on diffusion-weighted MR images: evidence supporting premyelination anisotropy. AJNR Am J Neuroradiol (2001) 0.98
Identification of a histidine residue near the aminoacyl transfer ribonucleic acid binding site of elongation factor Tu. Biochemistry (1981) 0.95
Designing recombinant spider silk proteins to control assembly. Int J Biol Macromol (1999) 0.95
Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction. J Struct Biol (1998) 0.94
Effects of ZnCl2 on membrane interactions in myelin of normal and shiverer mice. Biochim Biophys Acta (1984) 0.94
Refined fibril structures: the hydrophobic core in Alzheimer's amyloid beta-protein and prion as revealed by X-ray diffraction. Ciba Found Symp (1996) 0.94
Betabellins 15D and 16D, de Novo designed beta-sandwich proteins that have amyloidogenic properties. J Struct Biol (2000) 0.93
Processing for electron microscopy alters membrane structure and packing in myelin. J Ultrastruct Res (1980) 0.93
Involvement of arginine residues in the binding site of cholera toxin subunit B. Biochem Biophys Res Commun (1979) 0.91
Compaction and particle segregation in myelin membrane arrays. J Cell Biol (1981) 0.90
Collagen type II differs from type I in native molecular packing. Biochim Biophys Acta (1980) 0.90
Structural states of myelin observed by x-ray diffraction and freeze-fracture electron microscopy. J Cell Biol (1979) 0.88
Covalent structure of the gamma chain of the A subunit of cholera toxin. J Biol Chem (1981) 0.87
Tetrameric assembly of full-sequence protein zero myelin glycoprotein by synchrotron x-ray scattering. Biophys J (1999) 0.86
A beta fibrillogenesis: kinetic parameters for fibril formation from congo red binding. J Struct Biol (2000) 0.86
ADP-ribosyl transferase activity of cholera toxin polypeptide A1 and the effect of limited trypsinolysis. Biochem Biophys Res Commun (1981) 0.86
Clostridium perfringens type A enterotoxin: characterization of the amino-terminal region. Infect Immun (1982) 0.85
Histidine residues underlie Congo red binding to A beta analogs. Amyloid (2000) 0.85
Myelin P0-glycoprotein: predicted structure and interactions of extracellular domain. J Neurochem (1993) 0.85
A survey of neurological mutant mice. I. Lipid composition of myelinated tissue in known myelin mutants. Dev Neurosci (1988) 0.85
X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices. J Mol Biol (1997) 0.85
Is myelin basic protein crystallizable? Neurochem Res (1992) 0.85
Ganglioside localization on myelinated nerve fibres by cholera toxin binding. J Neurocytol (1983) 0.84
Shiverer and normal peripheral myelin compared: basic protein localization, membrane interactions, and lipid composition. J Neurochem (1985) 0.84
Stabilization of secondary structure of Alzheimer beta-protein by aluminum(III) ions and D-Asp substitutions. Biochem Biophys Res Commun (1995) 0.84
X-ray diffraction study of myelin structure in immature and mutant mice. Biochim Biophys Acta (1976) 0.83
Neutron diffraction studies of nerve myelin. Brookhaven Symp Biol (1976) 0.83
Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain. J Neurosci Res (2000) 0.83
Myelin labeled with mercuric chloride. Asymmetric localization of phosphatidylethanolamine plasmalogen. J Mol Biol (1982) 0.83
X-ray diffraction study of the kinetics of myelin lattice swelling. Effect of divalent cations. Biophys J (1979) 0.83
Membrane interactions are altered in myelin isolated from central and peripheral nervous system tissues. J Neurochem (1988) 0.82
X-ray diffraction analysis of myelin lipid/proteolipid protein multilayers. J Neurosci Res (1989) 0.82
Morphological evidence of alteration in myelinstructure with maturation. Brain Res (1976) 0.82
Natural exposure of coastal river otters to mercury: relation to age, diet, and survival. Environ Toxicol Chem (2001) 0.81
Thioridazine induces lipid peroxidation in myelin of rat brain. Neuropharmacology (1993) 0.80
Proton magnetic resonance in myelin deficient brains of mutant mice. J Neurol Sci (1989) 0.80
Immunolocalization of 17 and 21.5 kDa MBP isoforms in compact myelin and radial component. J Neurocytol (1996) 0.80
Isolation and characterization of a precursor form of the 'A' subunit of cholera toxin. FEBS Lett (1981) 0.80
Spinal cord myelin is vulnerable to decompression. Mol Chem Neuropathol (1997) 0.80
Differential expression of gangliosides on the surfaces of myelinated nerve fibers. J Neurosci Res (1984) 0.80
Diurnal and seasonal variations of melatonin and serotonin in women with seasonal affective disorder. Arctic Med Res (1994) 0.79
Radial component of CNS myelin: junctional subunit structure and supramolecular assembly. J Neurocytol (1990) 0.79
Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices. Chem Biol Interact (2001) 0.78
A survey of neurological mutant mice. II. Lipid composition of myelinated tissue in possible myelin mutants. Dev Neurosci (1988) 0.78
Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease. Neuroreport (2001) 0.78
Cholera toxin A subunit: functional sites correlated with regions of secondary structure. Arch Biochem Biophys (1985) 0.78
Protein and lipid composition of radial component-enriched CNS myelin. J Neurochem (1994) 0.78
Baseline concentrations of total mercury and methylmercury in salmon returning via the Bering Sea (1999-2000). Mar Pollut Bull (2001) 0.77
Orientation of proteolipid protein in myelin: comparison of models with X-ray diffraction measurements. Dev Neurosci (1989) 0.77
Effects of rumpshaker mutation on CNS myelin composition and structure. J Neurochem (1996) 0.77
High molecular weight microtubule-associated proteins: purification by electro-elution and amino acid compositions. J Neurosci Res (1986) 0.77
Triethyl tin-induced myelin oedema: an intermediate swelling state detected by X-ray diffraction. J Neurocytol (1982) 0.77
A note on the predicted secondary structures of the active chains of cholera and diphtheria toxins. Toxicon (1986) 0.77
Myelin membrane from adrenoleukodystrophy brain white matter--biochemical properties. J Neurochem (1983) 0.77
Diurnal and seasonal rhythms of melatonin, cortisol and testosterone in interior Alaska. Arctic Med Res (1994) 0.77
Interaction of synthetic Alzheimer beta-protein-derived analogs with aqueous aluminum: a low-field 27Al NMR investigation. J Protein Chem (1995) 0.76
Membrane topology of PLP in CNS myelin: evaluation of models. Neurochem Res (1994) 0.76
Implications of the sequence similarities between tau and myelin basic protein. Med Hypotheses (1995) 0.76